These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 34344552)

  • 1. Quantification of SARS-CoV-2 spike and nucleocapsid proteins using isotope dilution tandem mass spectrometry.
    Pierce-Ruiz C; Santana WI; Sutton WJH; Fischler DA; Cooper HC; Marc LR; Barr JR; Williams TL
    Vaccine; 2021 Aug; 39(36):5106-5115. PubMed ID: 34344552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous quantification of spike and nucleocapsid protein in inactivated COVID-19 vaccine bulk by liquid chromatography-tandem mass spectrometry.
    Long Z; Wei C; Dong X; Li X; Yang H; Deng H; Ma X; Yin S; Qi Y; Bo T
    J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Sep; 1181():122884. PubMed ID: 34411991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a Parallel Reaction Monitoring Mass Spectrometry Assay for the Detection of SARS-CoV-2 Spike Glycoprotein and Nucleoprotein.
    Cazares LH; Chaerkady R; Samuel Weng SH; Boo CC; Cimbro R; Hsu HE; Rajan S; Dall'Acqua W; Clarke L; Ren K; McTamney P; Kallewaard-LeLay N; Ghaedi M; Ikeda Y; Hess S
    Anal Chem; 2020 Oct; 92(20):13813-13821. PubMed ID: 32966064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative Assessment of SARS-CoV-2 Virus in Nasopharyngeal Swabs Stored in Transport Medium by a Straightforward LC-MS/MS Assay Targeting Nucleocapsid, Membrane, and Spike Proteins.
    Saadi J; Oueslati S; Bellanger L; Gallais F; Dortet L; Roque-Afonso AM; Junot C; Naas T; Fenaille F; Becher F
    J Proteome Res; 2021 Feb; 20(2):1434-1443. PubMed ID: 33497234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single Immunization with Recombinant ACAM2000 Vaccinia Viruses Expressing the Spike and the Nucleocapsid Proteins Protects Hamsters against SARS-CoV-2-Caused Clinical Disease.
    Deschambault Y; Lynch J; Warner B; Tierney K; Huynh D; Vendramelli R; Tailor N; Frost K; Sajesh B; LeBlanc K; Layne C; Lin L; Tamming L; Beniac D; Booth S; Carpenter M; Safronetz D; Li X; Kobasa D; Cao J
    J Virol; 2022 May; 96(9):e0038922. PubMed ID: 35412347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted Detection of SARS-CoV-2 Nucleocapsid Sequence Variants by Mass Spectrometric Analysis of Tryptic Peptides.
    Maus A; Renuse S; Kemp J; Madugundu AK; Vanderboom PM; Blommel J; Jerde C; Dasari S; Kipp BR; Singh RJ; Grebe SK; Pandey A
    J Proteome Res; 2022 Jan; 21(1):142-150. PubMed ID: 34779632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteotyping SARS-CoV-2 Virus from Nasopharyngeal Swabs: A Proof-of-Concept Focused on a 3 Min Mass Spectrometry Window.
    Gouveia D; Miotello G; Gallais F; Gaillard JC; Debroas S; Bellanger L; Lavigne JP; Sotto A; Grenga L; Pible O; Armengaud J
    J Proteome Res; 2020 Nov; 19(11):4407-4416. PubMed ID: 32697082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combining spike- and nucleocapsid-based vaccines improves distal control of SARS-CoV-2.
    Dangi T; Class J; Palacio N; Richner JM; Penaloza MacMaster P
    Cell Rep; 2021 Sep; 36(10):109664. PubMed ID: 34450033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spike vs nucleocapsid SARS-CoV-2 antigen detection: application in nasopharyngeal swab specimens.
    Barlev-Gross M; Weiss S; Ben-Shmuel A; Sittner A; Eden K; Mazuz N; Glinert I; Bar-David E; Puni R; Amit S; Kriger O; Schuster O; Alcalay R; Makdasi E; Epstein E; Noy-Porat T; Rosenfeld R; Achdout H; Mazor O; Israely T; Levy H; Mechaly A
    Anal Bioanal Chem; 2021 May; 413(13):3501-3510. PubMed ID: 33768365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evolution of SARS-CoV-2 Envelope, Membrane, Nucleocapsid, and Spike Structural Proteins from the Beginning of the Pandemic to September 2020: A Global and Regional Approach by Epidemiological Week.
    Troyano-Hernáez P; Reinosa R; Holguín Á
    Viruses; 2021 Feb; 13(2):. PubMed ID: 33557213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantification of SARS-CoV-2 spike protein expression from mRNA vaccines using isotope dilution mass spectrometry.
    Sutton WJH; Branham PJ; Williamson YM; Cooper HC; Najjar FN; Pierce-Ruiz CL; Barr JR; Williams TL
    Vaccine; 2023 Jun; 41(26):3872-3884. PubMed ID: 37202272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Multiplex Noninvasive Salivary Antibody Assay for SARS-CoV-2 Infection and Its Application in a Population-Based Survey by Mail.
    Egorov AI; Griffin SM; Fuzawa M; Kobylanski J; Grindstaff R; Padgett W; Simmons S; Hallinger DR; Styles JN; Wickersham L; Sams E; Hudgens E; Wade TJ
    Microbiol Spectr; 2021 Oct; 9(2):e0069321. PubMed ID: 34523986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. One-Step, Wash-free, Nanoparticle Clustering-Based Magnetic Particle Spectroscopy Bioassay Method for Detection of SARS-CoV-2 Spike and Nucleocapsid Proteins in the Liquid Phase.
    Wu K; Chugh VK; D Krishna V; di Girolamo A; Wang YA; Saha R; Liang S; Cheeran MC; Wang JP
    ACS Appl Mater Interfaces; 2021 Sep; 13(37):44136-44146. PubMed ID: 34499464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Operation Moonshot: rapid translation of a SARS-CoV-2 targeted peptide immunoaffinity liquid chromatography-tandem mass spectrometry test from research into routine clinical use.
    Hällqvist J; Lane D; Shapanis A; Davis K; Heywood WE; Doykov I; Śpiewak J; Ghansah N; Keevil B; Gupta P; Jukes-Jones R; Singh R; Foley D; Vissers JPC; Pattison R; Ferries S; Wardle R; Bartlett A; Calton LJ; Anderson L; Razavi M; Pearson T; Pope M; Yip R; Ng LL; Nicholas BI; Bailey A; Noel D; Dalton RN; Heales S; Hopley C; Pitt AR; Barran P; Jones DJL; Mills K; Skipp P; Carling RS
    Clin Chem Lab Med; 2023 Jan; 61(2):302-310. PubMed ID: 36395058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection, Mapping, and Proteotyping of SARS-CoV-2 Coronavirus with High Resolution Mass Spectrometry.
    Dollman NL; Griffin JH; Downard KM
    ACS Infect Dis; 2020 Dec; 6(12):3269-3276. PubMed ID: 33205948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mild SARS-CoV-2 Illness Is Not Associated with Reinfections and Provides Persistent Spike, Nucleocapsid, and Virus-Neutralizing Antibodies.
    Schuler CF; Gherasim C; O'Shea K; Manthei DM; Chen J; Zettel C; Troost JP; Kennedy AA; Tai AW; Giacherio DA; Valdez R; Baldwin JL; Baker JR
    Microbiol Spectr; 2021 Oct; 9(2):e0008721. PubMed ID: 34468184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of COVID-19 convalescent plasma for SARS-CoV-2 IgG using two commercial immunoassays.
    DomBourian MG; Annen K; Huey L; Andersen G; Merkel PA; Jung S; Dominguez SR; Knight V
    J Immunol Methods; 2020 Nov; 486():112837. PubMed ID: 32828791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular characterization of SARS-CoV-2 nucleocapsid protein.
    Huang Y; Chen J; Chen S; Huang C; Li B; Li J; Jin Z; Zhang Q; Pan P; Du W; Liu L; Liu Z
    Front Cell Infect Microbiol; 2024; 14():1415885. PubMed ID: 38846351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A rapid and reliable liquid chromatography/mass spectrometry method for SARS-CoV-2 analysis from gargle solutions and saliva.
    Kipping M; Tänzler D; Sinz A
    Anal Bioanal Chem; 2021 Nov; 413(26):6503-6511. PubMed ID: 34427712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An isotope dilution mass spectrometry assay to track Norovirus-like particles in vaccine process intermediates by quantifying capsid protein VP1.
    Jhingree JR; Boisvert J; Mercier G
    Anal Methods; 2023 Jun; 15(22):2729-2735. PubMed ID: 37199095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.